Showing results (31-40 of 45) with videos related to
Sort By:
Pageof 5
Blood|December 25, 2023
Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomasLaQuisa C Hill, Rayne H Rouce, Mengfen J Wu, et al.Blood Advances|June 24, 2025
Real-world data for tisagenlecleucel in patients with R/R B-ALL: subgroup analyses from the CIBMTR registrySamuel John, Kevin J Curran, Erin M Hall, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2021
T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical EffectsSpyridoula Vasileiou, Premal D Lulla, Ifigeneia Tzannou, et al.Blood|March 24, 2022
Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECsDavid H M Steffin, Ibrahim N Muhsen, LaQuisa C Hill, et al.Cancers|December 5, 2020
Defining the Inflammatory Plasma Proteome in Pediatric Hodgkin LymphomaJennifer E Agrusa, Brooks P Scull, Harshal A Abhyankar, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2019
T-Cell Receptor Stimulation Enhances the Expansion and Function of CD19 Chimeric Antigen Receptor-Expressing T CellsNatalia Lapteva, Margaret Gilbert, Iulia Diaconu, et al.Blood|March 11, 2025
Social Determinants of Health and Access to Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid LeukemiaNatalie Wuliji, Salene M W Jones, Ted A Gooley, et al.Cancer Immunology Research|February 17, 2022
A Costimulatory CAR Improves TCR-based Cancer ImmunotherapyBilal Omer, Mara G Cardenas, Thomas Pfeiffer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2021
Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium ReportLiora M Schultz, Christina Baggott, Snehit Prabhu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 11, 2023
Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT SettingThomas Pfeiffer, Ifigeneia Tzannou, Mengfen Wu, et al.Pageof 5